Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

  • ContraFect (NASDAQ:CFRX) stock increased by 4.9% to $2.76 during Thursday's after-market session. The company's market cap stands at $108.5 million.
  • Lexaria Bioscience (NASDAQ:LEXX) shares moved upwards by 4.76% to $4.51. The company's market cap stands at $26.8 million.
  • Atossa Therapeutics (NASDAQ:ATOS) shares increased by 4.57% to $1.6. The market value of their outstanding shares is at $202.5 million.
  • Enveric Biosciences (NASDAQ:ENVB) stock increased by 4.42% to $0.9. The market value of their outstanding shares is at $29.4 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock rose 4.02% to $1.81. The market value of their outstanding shares is at $15.1 million.
  • Chembio Diagnostics (NASDAQ:CEMI) stock rose 3.66% to $1.13. The company's market cap stands at $33.9 million.

Losers

  • Plus Therapeutics (NASDAQ:PSTV) shares fell 6.8% to $1.23 during Thursday's after-market session. Today's trading volume for this security ended up closing at 103.7K shares, which is 4.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $18.8 million.
  • Graphite Bio (NASDAQ:GRPH) shares declined by 6.23% to $10.4. The market value of their outstanding shares is at $604.0 million.
  • Ikena Oncology (NASDAQ:IKNA) stock declined by 5.43% to $11.5. The market value of their outstanding shares is at $412.9 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock fell 5.04% to $0.51. The company's market cap stands at $7.8 million.
  • BiondVax Pharmaceuticals (NASDAQ:BVXV) stock declined by 4.88% to $1.95. The company's market cap stands at $36.0 million.
  • Ensysce Biosciences (NASDAQ:ENSC) stock fell 4.64% to $4.53. Trading volume for this security closed at 137.7K, accounting for 2.1% of its average full-day volume over the last 100 days. The company's market cap stands at $109.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.